Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Lamsfus

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
NPJ Vaccines|August 23, 2022
A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infectionBenjamin Mordmüller, Zita Sulyok, Mihály Sulyok, et al.
Nature Communications|May 5, 2021
Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trialZita Sulyok, Rolf Fendel, Bianca Eder, et al.
Malaria Journal|April 19, 2015
Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centresBenjamin Mordmüller, Christian Supan, Kim Lee Sim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2019
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated MalariaBenjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, et al.
Nature|February 16, 2017
Sterile protection against human malaria by chemoattenuated PfSPZ vaccineBenjamin Mordmüller, Güzin Surat, Heimo Lagler, et al.
EMBO Molecular Medicine|September 29, 2025
Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanilSteffen Borrmann, Zita Sulyok, Katja Müller, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
NPJ Vaccines|August 23, 2022
A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infectionBenjamin Mordmüller, Zita Sulyok, Mihály Sulyok, et al.
Nature Communications|May 5, 2021
Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trialZita Sulyok, Rolf Fendel, Bianca Eder, et al.
Malaria Journal|April 19, 2015
Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centresBenjamin Mordmüller, Christian Supan, Kim Lee Sim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2019
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated MalariaBenjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, et al.
Nature|February 16, 2017
Sterile protection against human malaria by chemoattenuated PfSPZ vaccineBenjamin Mordmüller, Güzin Surat, Heimo Lagler, et al.
EMBO Molecular Medicine|September 29, 2025
Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanilSteffen Borrmann, Zita Sulyok, Katja Müller, et al.
Pageof 2